Company Filing History:
Years Active: 2012
Title: Yong-Sung Shon: Innovator in Pharmaceutical Composition
Introduction
Yong-Sung Shon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dry eye syndrome. His innovative work has led to the development of a unique compound that has potential therapeutic applications.
Latest Patents
Yong-Sung Shon holds a patent for "3',4′,5-trimethoxy flavone derivatives as stimulant of mucus secretion, method for the same, and pharmaceutical composition comprising the same." This invention provides a 3',4′,5-trimethoxy flavone derivative and a pharmaceutically acceptable salt thereof. The patent outlines a pharmaceutical composition for the treatment and prevention of dry eye syndrome, which includes this derivative as an active ingredient. The compound is designed to inhibit corneal damage by stimulating mucus secretion in the conjunctiva, making it a promising candidate for both prophylactic and therapeutic use.
Career Highlights
Yong-Sung Shon is associated with Dong-a Pharm. Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.
Collaborations
He collaborates with esteemed colleagues such as Seul-Min Choi and Kyung-Koo Kang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Yong-Sung Shon is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of dry eye syndrome. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.